A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Completed · Phase 4

Conditions studied: Detrusor Hyperreflexia

In brief

This study will evaluate the efficacy and safety of an anticholinergic drug treatment administered by transdermal patch to treat overactive bladder in adults who have spinal cord injury.

Key facts

Study ID
NCT00224029
Run by
Watson Pharmaceuticals
People needed
24
Starts
2004-12-01
Expected to finish
2008-05-01
Last updated by the study team
2010-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.